Found 92 matching trials
TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated Donors PHASE2 The purpose of this study is to find out if removing a specific type of whi...
Show More Location
Memorial SloanKettering Cancer Center
Learn More & Join Trial
Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants PHASE4 The primary purpose of this study is to evaluate the pulse wave velocity an...
Show More Status
Active Not Recruiting
Location
Hospital of the University of Pennsylvania
Learn More & Join Trial
Belatacept to Prevent Organ Rejection in Kidney Transplant Patients PHASE2 Belatacept is an experimental medication shown in clinical trials to have i...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma PHASE1 Neuroblastoma is a malignant tumor of the sympathetic nervous system. It is...
Show More Location
Columbia Presbyterian Medical Center, Morgan Stanley Children's Hospital New York Presbyterian
Learn More & Join Trial
Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients PHASE2 This phase II trial studies how well tacrolimus, bortezomib, and anti-thymo...
Show More Location
Emory University/Winship Cancer Institute
Learn More & Join Trial
Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients PHASE3 Allogeneic (Allo) hematopoietic stem cell transplantation (HSCT) is a recog...
Show More Learn More & Join Trial
Study of Antithymocyte Globulin for Treatment of New-onset T1DM PHASE2 Antithymocyte globulin (e.g., Thymoglobulin®) is an antibody preparation th...
Show More Location
Children's Hospital/USC School of Medicine
Learn More & Join Trial
ATG Versus Basiliximab in Kidney Transplant Displaying Low Immunological Risk But High Susceptibility to DGF PHASE4 The primary objective of the following randomized open label trial is to de...
Show More Location
Universitary hospital of Lyon
Learn More & Join Trial
Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome PHASE2 The goal of this clinical research study is to learn if combining the drugs...
Show More Location
UT MD Anderson Cancer Center
Learn More & Join Trial
mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation PHASE3 This study is designed to evaluate efficacity and safety of everolimus or (...
Show More Learn More & Join Trial